SCHEMBL768864

SCHEMBL768864

Nc1cnccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL26962783 0.97
SCHEMBL767020 0.79
SCHEMBL16307599 0.79
SCHEMBL31313018 0.79
Amifampridine SCHEMBL21273 0.75
Amifampridine SCHEMBL29354458 0.75
SCHEMBL29518741 0.75
SCHEMBL3717170 0.75
Amifampridine SCHEMBL19410631 0.72 GAA (0.56)
Amifampridine SCHEMBL30609183 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051301-A1 MUTANT IDH1 AND IDH2 INHIBITOR AND APPLICATION THEREOF BETTA PHARMACEUTICALS CO., LTD (CN) 2025-02-13 US disclosed
CN-118786119-A Mutant IDH1 and IDH2 inhibitors and application thereof 贝达药业股份有限公司 2024-10-15 CN disclosed
CN-117551262-A Liquid crystal copolyester and preparation method thereof 海利得新材料研究(上海)有限公司 2024-02-13 CN disclosed
US-20230380280-A1 ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-23 US disclosed
US-20230380280-A1 ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-23 US disclosed
WO-2023174235-A1 MUTANT IDH1 AND IDH2 INHIBITOR AND APPLICATION THEREOF 贝达药业股份有限公司 2023-09-21 WO disclosed
CN-114391012-A Pyridine derivatives as KIF18A inhibitors 美国安进公司 2022-04-22 CN disclosed
US-9670192-B2 Substituted isoxazole derivatives BASF SE (DE) 2017-06-06 US disclosed
EP-2475659-B1 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE HOFFMANN LA ROCHE (CH) 2015-10-28 EP disclosed
US-20140315886-A1 QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-10-23 US disclosed
US-8435976-B2 4-substituted pyridin-3-yl-carboxamide compounds and methods of use F. HOFFMANN-LA ROCHE (CH) 2013-05-07 US disclosed
EP-2475659-A1 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2012-07-18 EP disclosed
US-20120071516-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-22 US disclosed
US-20120071516-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-22 US disclosed
WO-2011029802-A1 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2011-03-17 WO disclosed
US-20110059961-A1 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE GENENTECH, INC. 2011-03-10 US disclosed
EP-1066289-B1 PREPARATION OF N-ARYLARYLSULFONAMIDE COMPOUNDS DOW AGROSCIENCES LLC (US) 2003-11-19 EP disclosed
EP-1066289-A1 PREPARATION OF N-ARYLARYLSULFONAMIDE COMPOUNDS Dow AgroSciences LLC (US) 2001-01-10 EP disclosed
US-5959106-A REACTING A CHLOROSULFONYLARYL COMPOUND WITH AN ARYLAMINE IN PRESENCE OF ORGANIC ALCOHOL SOLVENT DOW AGROSCIENCES LLC (US) 1999-09-28 US disclosed
WO-1999037650-A1 PREPARATION OF N-ARYLARYLSULFONAMIDE COMPOUNDS DOW AGROSCIENCES LLC (US) 1999-07-29 WO disclosed